期刊文献+

降压药物联用治疗老年性单纯收缩期高血压效果 被引量:1

EFFECT OF COMBINED THERAPY ON ELDERLY PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION
下载PDF
导出
摘要 目的探讨联合应用降压药物治疗老年性单纯收缩期高血压的效果。方法对48例老年性单纯收缩期高血压、服用单一药物血压控制不良病人联合应用降压药物治疗,缬沙坦80 mg每日1次早6:00时服用,伲福达10 mg每日1次晚饭前服。分别于联合用药前和用药1个月后测血压值并进行比较。结果联合应用降压药物前后收缩压比较差异有显著性(t=5.217,P<0.01),而舒张压比较差异无显著性(t=1.354,P>0.05)。结论缬沙坦、伲福达联合应用治疗老年性单纯收缩期高血压效果较好,尤其是对服用单一药物血压控制不良者。 Objective To evaluate the effect of combined therapy on elderly patients with isolated systolic hypertension. Methods Forty-eight patients with isolated systolic hypertension who failed to control blood pressure by taking a single medication were treated with a combined-drug therapy, of valsartan 80 mg, once a day at 6 am, and nifedipine 10 mg, once a day before supper. Blood pressure was measured before and one month after the therapy. Results Compared with before the combined treatment, systolic blood pressure after the treatment showed significantly different (t=5. 217,P〈0.01), but no significant difference was noted for diastolic pressure. Conclusion Combined therapy with valsartan and nifedipine is better for aged patients with isolated systolic hypertension, especially for those who failed to control the blood pressure with a single medication.
出处 《齐鲁医学杂志》 2008年第4期337-338,共2页 Medical Journal of Qilu
关键词 高血压 缬沙坦 伲福达 老年人 治疗结果 Hypertention Valsartan Nifuda Aged Treatment outcome
  • 相关文献

参考文献4

二级参考文献10

  • 1Chobanian AV,Bakris GL,Black HR,et al. The seventh report of the joint national committee on prevention,Detection, Evaluation,and Treatment of high blood pressure. JAMA,2003,289:2560-2572.
  • 2PROGRESS Collaborative Study Group. Randomised trial of perindopril based blood pressure-lowering regimen among 6180 individuals with previous stroke or transient ischaemic attack. Lancet,2001,358 : 1033-1041.
  • 3The ALLHAT officers and coordinators for the ALLHAT Collaborative research group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diurrtic. JAMA,2002,288:2981-2997.?A?A
  • 4RE R.The myocardial intracellular renin-angiotensin system[J].Am J Cardiol,1987,59:56.
  • 5GRINSREAD W,YOUNG J B.The myocardial rennin-angiotensin system,existence importance and clinical implications[J].Am Heart J,1992,123:1039.
  • 6CUOCOLO A,SAX F L,BRUSH J E,et al.Left ventricular hypertrophy and impaired diastolic filling in essential hypertension[J].Circulation,1990,81:978.
  • 7BRILLA G C,SCHEER C,RUPP H.Renin-angiotensin system and myocardial collagen matrix:modulation of cardiac fibroblast function by angiotensin Ⅱ type Ⅰ receptor antagonism[J].J Hypertens,1997,15 (Suppl 6):513.
  • 8FLESCH M,SCHIFFER F,ZOLK O,et al.Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca2+-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy[J].J Hypertens,1997,15:1001.
  • 9SAGASTAGOITIZ D,MORILLAS M,MURGA N,et al.Functional and organic components of diastolic dysfunction in hypertensive heart disease:therapeutic implications[J].Eur Heart J,1993,14 (Suppl J):107.
  • 10FARIAS C A,RODRIGUEZ L,GARCIA M J,et al.Assessment of diastolic function by tissue Doppler[J].J Am Soc Echocardiogr,1999,12:609.

共引文献66

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部